Free Trial
OTCMKTS:TEAR

TearLab (TEAR) Stock Price, News & Analysis

TearLab logo
$0.06 0.00 (-1.86%)
As of 07/9/2020

About TearLab Stock (OTCMKTS:TEAR)

Key Stats

Today's Range
$0.06
$0.06
50-Day Range
$0.06
$0.06
52-Week Range
$0.02
$0.22
Volume
20,200 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TEAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TearLab and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TEAR Stock News Headlines

Harrow Announces New Appointments to its Board of Directors
STRATA Skin Science Announces Leadership Change
"I'm risking my reputation on this"
The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy… it's the starting gun for what I'm calling the "Great Crypto Revolution."tc pixel
Lawrence schools on 'good footing' financially
Pathway Makes Four Senior Promotions
See More Headlines

TEAR Stock Analysis - Frequently Asked Questions

TearLab's stock was trading at $0.0579 at the start of the year. Since then, TEAR stock has increased by 0.0% and is now trading at $0.0579.

TearLab Corporation (OTCMKTS:TEAR) announced its earnings results on Thursday, August, 8th. The medical research company reported ($0.10) earnings per share (EPS) for the quarter. The medical research company had revenue of $5.85 million for the quarter.

TearLab's stock reverse split on Friday, February 24th 2017.The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 23rd 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of TEAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TearLab investors own include Vertex Energy (VTNR), Protalix BioTherapeutics (PLX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Immunomedics (IMMU), CorMedix (CRMD) and Rigel Pharmaceuticals (RIGL).

Company Calendar

Last Earnings
8/08/2019
Today
10/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:TEAR
Previous Symbol
NASDAQ:TEAR
CIK
1299139
Employees
34
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:TEAR) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners